Glaukos Corporation (GKOS)

NYSE: GKOS · Real-Time Price · USD

144.01

+1.86 (1.31%)

May 15, 2026, 4:00 PM EDT - Market closed

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
United States Revenue	412.32M	375.04M	270.09M
United States Revenue Growth	9.94%	38.86%	23.11%
International Revenue	139.03M	132.40M	113.39M
International Revenue Growth	5.01%	16.77%	18.96%
Revenue (Total)	551.35M	507.44M	383.48M
Revenue (Total) Growth	8.65%	32.32%	21.85%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Glaucoma Revenue	462.19M	421.07M	303.28M
Glaucoma Revenue Growth	9.77%	38.84%	27.94%
Corneal Health Revenue	89.16M	86.37M	80.21M
Corneal Health Revenue Growth	3.22%	7.69%	3.26%
Revenue (Total)	551.35M	507.44M	383.48M
Revenue (Total) Growth	8.65%	32.32%	21.85%

Updated Apr 29, 2026. Data Source: Fiscal.ai.